Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

COVID-19 in people with rheumatic diseases: risks, outcomes, treatment considerations
Rebecca Grainger, Alfred H.J. Kim, Richard Conway, et al.
Nature Reviews Rheumatology (2022) Vol. 18, Iss. 4, pp. 191-204
Open Access | Times Cited: 159

Showing 1-25 of 159 citing articles:

Current and Emerging Knowledge in COVID-19
Yeon Joo Jeong, Yu Mi Wi, Hyunjin Park, et al.
Radiology (2023) Vol. 306, Iss. 2
Open Access | Times Cited: 72
The Flare of Rheumatic Disease After SARS-CoV-2 Vaccination: A Review
Yan Xie, Yang Liu, Yi Liu
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 42
Impacto da infecção por COVID-19 em pacientes com doenças reumáticas autoimunes
Santiago Martín Sánchez Peralta, Karina Fernanda Pucha Aguinsaca, Homero Abel Chacho Aucay, et al.
Brazilian Journal of Health Review (2023) Vol. 6, Iss. 1, pp. 2103-2118
Open Access | Times Cited: 23
Factors associated with COVID-19 breakthrough infection among vaccinated patients with rheumatic diseases: A cohort study
Naomi J. Patel, Xiaosong Wang, Xiaoqing Fu, et al.
Seminars in Arthritis and Rheumatism (2022) Vol. 58, pp. 152108-152108
Open Access | Times Cited: 36
Prolonged COVID-19 symptom duration in people with systemic autoimmune rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey
Michael DiIorio, Kevin Kennedy, Jean W. Liew, et al.
RMD Open (2022) Vol. 8, Iss. 2, pp. e002587-e002587
Open Access | Times Cited: 34
Early Outpatient Treatment With Remdesivir in Patients at High Risk for Severe COVID-19: A Prospective Cohort Study
Sandra Rajme‐López, Bernardo Alfonso Martínez-Guerra, Jessica Zalapa‐Soto, et al.
Open Forum Infectious Diseases (2022) Vol. 9, Iss. 10
Open Access | Times Cited: 30
Diagnosing and treating ANCA-associated vasculitis: an updated review for clinical practice
Baptiste Chevet, Divi Cornec, Marta Casal Moura, et al.
Lara D. Veeken (2022) Vol. 62, Iss. 5, pp. 1787-1803
Closed Access | Times Cited: 28
Vaccine hesitancy decreases in rheumatic diseases, long-term concerns remain in myositis: a comparative analysis of the COVAD surveys
Parikshit Sen, R Naveen, Nazanin Houshmand, et al.
Lara D. Veeken (2023) Vol. 62, Iss. 10, pp. 3291-3301
Open Access | Times Cited: 17
Modern concept of autoimmunity in rheumatology
Е. Л. Насонов
Rheumatology Science and Practice (2023) Vol. 61, Iss. 4, pp. 397-420
Open Access | Times Cited: 16
Characteristics associated with poor COVID-19 outcomes in people with psoriasis, psoriatic arthritis and axial spondyloarthritis: data from the COVID-19 PsoProtect and Global Rheumatology Alliance physician-reported registries
Pedro Machado, Martin Schäfer, Satveer K. Mahil, et al.
Annals of the Rheumatic Diseases (2023) Vol. 82, Iss. 5, pp. 698-709
Open Access | Times Cited: 15
Antibody and B Cell Responses to SARS-CoV-2 Infection and Vaccination: The End of the Beginning
Katharina Röltgen, Scott D. Boyd
Annual Review of Pathology Mechanisms of Disease (2023) Vol. 19, Iss. 1, pp. 69-97
Open Access | Times Cited: 15
CAR T Cells — A New Horizon for Autoimmunity?
John D. Isaacs
New England Journal of Medicine (2024) Vol. 390, Iss. 8, pp. 758-759
Closed Access | Times Cited: 5
Coronavirus disease 2019 (COVID-19) pandemic and autoimmune rheumatic diseases: Outcomes and prospects
Е. Л. Насонов
Rheumatology Science and Practice (2024) Vol. 62, Iss. 1, pp. 32-54
Open Access | Times Cited: 5
Recommendations for the diagnosis and treatment of anti-neutrophil cytoplasmic autoantibody associated vasculitis
Enrique Morales, Íñigo Rúa‐Figueroa, José Luis Callejas‐Rubio, et al.
Nefrología (English Edition) (2025)
Open Access
Impact long COVID on self-reported disease activity, disability, and quality of life in individuals with inflammatory arthritis
Zachary S. Wallace, Lin Miao, Shruthi Srivatsan, et al.
Seminars in Arthritis and Rheumatism (2025) Vol. 71, pp. 152657-152657
Closed Access
Modelling multiscale infectious disease in complex systems
Jiajun Xian, Minghui Liu, Xuan Cheng, et al.
Physics Reports (2025) Vol. 1113, pp. 1-57
Closed Access
Shielding the immunocompromised: COVID-19 prevention strategies for patients with primary and secondary immunodeficiencies
G. Olivieri, Donato Amodio, Emma Concetta Manno, et al.
Vaccine (2025) Vol. 51, pp. 126853-126853
Open Access
Community-engaged curriculum development using racial justice and biomedical lenses to address COVID-19 vaccine hesitancy in black individuals with rheumatologic conditions
Eseosa Olive Osaghae, Greta Sirek, Tonya Roberson, et al.
Frontiers in Public Health (2025) Vol. 12
Open Access
ORCHESTRA Delphi Consensus: Diagnostic and Therapeutic Management of SARS-CoV-2 Infection in Rheumatological Patients
Maria Giulia Caponcello, Pedro Navarro, Cecilia Bonazzetti, et al.
Clinical Microbiology and Infection (2025)
Closed Access
Different COVID-19 outcomes among systemic rheumatic diseases: a nation-wide cohort study
Vasiliki-Kalliopi Bournia, G. Fragoulis, Panagiota Mitrou, et al.
Lara D. Veeken (2022) Vol. 62, Iss. 3, pp. 1047-1056
Open Access | Times Cited: 26
COVID-19 and Inborn Errors of Immunity
Ottavia M. Delmonte, Riccardo Castagnoli, Luigi D. Notarangelo
Physiology (2022) Vol. 37, Iss. 6, pp. 290-301
Open Access | Times Cited: 24
Withholding methotrexate after vaccination with ChAdOx1 nCov19 in patients with rheumatoid or psoriatic arthritis in India (MIVAC I and II): results of two, parallel, assessor-masked, randomised controlled trials
Teny Grace Skaria, Anu Sreeprakash, Rashwith Umesh, et al.
The Lancet Rheumatology (2022) Vol. 4, Iss. 11, pp. e755-e764
Open Access | Times Cited: 22
Safety and immunogenicity of a third COVID-19 vaccination in patients with immune-mediated inflammatory diseases compared with healthy controls
Felix Kartnig, Daniel Mrak, Elisabeth Simader, et al.
Annals of the Rheumatic Diseases (2022) Vol. 82, Iss. 2, pp. 292-300
Open Access | Times Cited: 22
Type of vaccine and immunosuppressive therapy but not diagnosis critically influence antibody response after COVID-19 vaccination in patients with rheumatic disease
Leonie Maria Frommert, Amanthi Nadira Arumahandi de Silva, Jan Zernicke, et al.
RMD Open (2022) Vol. 8, Iss. 2, pp. e002650-e002650
Open Access | Times Cited: 20
Influence of the COVID-19 Pandemic on Medical Management and on Healthcare Delivery of Immune-Mediated Rheumatic and Musculoskeletal Diseases during the First Pandemic Period February to July 2020: A Systematic Review
Marco Schlegel, Stefan Bachmann
Medicina (2024) Vol. 60, Iss. 4, pp. 596-596
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top